Diabetes

GUARD Against PVR: Methotrexate for Proliferative Vitreoretinopathy After Retinal Detachment Surgery

The phase 3 GUARD trial is evaluating the safety and efficacy of this innovation.

October 2018

Retina News

May/June 2018

Retina News

April 2018

News

View More Articles